Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNF alpha therapy: results from the COIN study

Author(s):
Valk, M.E. van der; Mangen, M.J.J.; Leenders, M.; Dijkstra, G.; Bodegraven, A.A. van; Fidder, H.H.; Jong, D.J. de; Pierik, M.; Woude, C.J. van der; Romberg-Camps, M.J.L.; Clemens, C.H.M.; Jansen, J.M.; Mahmmod, N.; Meeberg, P.C. van de; Meulen-de Jong, A.E. van der; Ponsioen, C.Y.; Bolwerk, C.J.M.; Vermeijden, J.R.; Siersema, P.D.; Oijen, M.G.H. van; Oldenburg, B.; COIN Study Grp; Dutch Initiative Crohn Colitis
Published
2014
Publication type
Article / Letter to editor
Inflammatory Bowel DiseaseCrohn's DiseaseUlcerative ColitisEconomic Evaluation
Date issued
2014-01-31
Language
English
Is part of
Gut (2014), Vol. 63, no. 1, p. 72-79
hdl
1887/117384
doi
10.1136/gutjnl-2012-303376